News + Resources
Life Sciences M&A – A Necessary and Anticipated Step in Advancing Early-Stage Breakthroughs
For many early-stage life sciences companies, mergers and acquisitions (M&A) and other collaborations are fundamental to advancing promising new discoveries. An acquisition by a larger, more established company often represents a necessary and anticipated milestone in an early-stage company’s journey to bring a new breakthrough from the lab to the patient.
New BIO & TEConomy Report and the Importance of Life Sciences M&A
A recent report from BIO and TEConomy notes that decades of growth in the life sciences have been “rooted in, and enabled by, basic and applied research and development activities; development of, and access to, a qualified and highly skilled workforce; [and]...
Innovations Advanced by M&A: A Breakthrough Precision Therapy for Rare Cancers
In the case of Ignyta’s acquisition by Roche, M&A played a pivotal role in accelerating a new precision therapy to patients battling rare forms of cancer.
Founded in 2011 by Drs. David Lim and Gary Firestein, Ignyta initially focused on developing diagnostics for rheumatoid arthritis. However, after facing early scientific setbacks, the company pivoted its focus to advancing entrectinib, a promising investigational therapy for certain types of cancer caused by rare genetic mutations, along with developing diagnostic tests to help identify these mutations.
Preserving Michigan’s Competitive Bioscience Industry
In a recent op-ed for the Detroit News, Stephen Rapundalo, President and CEO of PULSE Partner MichBio, highlights the vital role of mergers and acquisitions (M&A) in fueling innovation and competition across Michigan’s life sciences ecosystem. As Rapundalo...
Forbes Commentary: Trump Administration Should Reverse “Anti-Merger” Approach to M&A
The culmination of flawed antitrust policies by the Federal Trade Commission (FTC) and Department of Justice (DOJ) have discouraged pro-competitive mergers that could meaningfully benefit American consumers – a growing concern raised by former FTC general counsel and...